Improving Effect of Traditional Chinese Medicine on Diabetic Nephropathy via Regulating MCP-1 and TNF-α
- VernacularTitle:中药及提取物调节单核细胞趋化蛋白1、肿瘤坏死因子-α对糖尿病肾病改善作用
- Author:
Benhong ZHOU
;
Jing WANG
- Keywords:
Diabetic nephropathy;
MCP-1;
TNF-α;
Traditional Chinese medicines
- From:
China Pharmacist
2017;20(3):534-537
- CountryChina
- Language:Chinese
-
Abstract:
Diabetic nephropathy ( DN) is one of the complications of diabetes, which is closely related to the pathogenesis of in-flammation. This article summarized the relevant literatures on the correlation between MCP-1 , TNF-α and DN, and the intervention of traditional Chinese medicine with DN. In kidney tissues, oxidative stress and NF-κB-dependent signal pathways induced the increase of monocyte chemoattractant protein-1 (MCP-1) expression, which could induce macrophage accumulation, proteinuria increase, renal fibrosis and renal clearance capacity decrease, and further leading to kidney damage. The clinical and experimental trails showed tumor necrosis factorαmRNA and protein levels in serum, urine and renal tissues were closely related with DN, which could be used as a bio marker to provide clinical guidance. As the therapeutic targets,MCP-1 and TNF-αcould give a novel insight into the clinical treatment of DN. Some traditional Chinese medicines or monomer could ameliorate DN by inhibiting MCP-1 and/or TNF-α. Thus, further verifi-cation or clinical application of those traditional Chinese medicines is worth trying.
